Journal of Experimental & Clinical Cancer Research

Papers
(The H4-Index of Journal of Experimental & Clinical Cancer Research is 65. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Emerging roles and the regulation of aerobic glycolysis in hepatocellular carcinoma277
The role of microenvironment in tumor angiogenesis260
Pyroptosis: a new paradigm of cell death for fighting against cancer209
Regulatory mechanisms of immune checkpoints PD-L1 and CTLA-4 in cancer192
Circular RNA circ-CPA4/ let-7 miRNA/PD-L1 axis regulates cell growth, stemness, drug resistance and immune evasion in non-small cell lung cancer (NSCLC)192
CAR race to cancer immunotherapy: from CAR T, CAR NK to CAR macrophage therapy158
Relevance of immune cell and tumor microenvironment imaging in the new era of immunotherapy153
Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways146
TM4SF1 promotes EMT and cancer stemness via the Wnt/β-catenin/SOX2 pathway in colorectal cancer136
Oral mucositis: the hidden side of cancer therapy136
Metformin induces Ferroptosis by inhibiting UFMylation of SLC7A11 in breast cancer134
Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples133
RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer133
Targeting hypoxia in the tumor microenvironment: a potential strategy to improve cancer immunotherapy132
Statins: a repurposed drug to fight cancer131
Non-coding RNAs in cancer: platforms and strategies for investigating the genomic “dark matter”130
RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent127
Single‐cell RNA sequencing in cancer research124
Pyroptosis at the forefront of anticancer immunity119
ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer115
Tumor-associated macrophages in cancer: recent advancements in cancer nanoimmunotherapies114
Exosomal miRNAs in tumor microenvironment107
LncRNA PSMB8-AS1 contributes to pancreatic cancer progression via modulating miR-382-3p/STAT1/PD-L1 axis100
Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets100
LINC00460/DHX9/IGF2BP2 complex promotes colorectal cancer proliferation and metastasis by mediating HMGA1 mRNA stability depending on m6A modification99
Emerging therapies for glioblastoma: current state and future directions97
Variants of uncertain significance in the era of high-throughput genome sequencing: a lesson from breast and ovary cancers96
Sec62 promotes stemness and chemoresistance of human colorectal cancer through activating Wnt/β-catenin pathway89
Natural product triptolide induces GSDME-mediated pyroptosis in head and neck cancer through suppressing mitochondrial hexokinase-ΙΙ88
m6A modification in RNA: biogenesis, functions and roles in gliomas86
Exosomal MALAT1 sponges miR-26a/26b to promote the invasion and metastasis of colorectal cancer via FUT4 enhanced fucosylation and PI3K/Akt pathway86
microRNA-96 promotes occurrence and progression of colorectal cancer via regulation of the AMPKα2-FTO-m6A/MYC axis84
Epigenetic regulation of ferroptosis via ETS1/miR-23a-3p/ACSL4 axis mediates sorafenib resistance in human hepatocellular carcinoma84
Immunotherapy for glioblastoma: the promise of combination strategies84
Long non-coding RNA H19 promotes colorectal cancer metastasis via binding to hnRNPA2B183
Cancer-associated adipocytes: emerging supporters in breast cancer83
Progranulin induces immune escape in breast cancer via up-regulating PD-L1 expression on tumor-associated macrophages (TAMs) and promoting CD8+ T cell exclusion82
Exosome-mediated transfer of miR-93-5p from cancer-associated fibroblasts confer radioresistance in colorectal cancer cells by downregulating FOXA1 and upregulating TGFB381
Apatinib triggers autophagic and apoptotic cell death via VEGFR2/STAT3/PD-L1 and ROS/Nrf2/p62 signaling in lung cancer79
Noncoding RNAs regulate alternative splicing in Cancer78
Chemotherapy-elicited exosomal miR-378a-3p and miR-378d promote breast cancer stemness and chemoresistance via the activation of EZH2/STAT3 signaling77
Targeting tumor hypoxia and mitochondrial metabolism with anti-parasitic drugs to improve radiation response in high-grade gliomas76
Dexosomes as a cell-free vaccine for cancer immunotherapy75
LncRNA-mediated DNA methylation: an emerging mechanism in cancer and beyond73
CircRNA_0000392 promotes colorectal cancer progression through the miR-193a-5p/PIK3R3/AKT axis72
The role of extracelluar matrix in osteosarcoma progression and metastasis72
Alternative polyadenylation: methods, mechanism, function, and role in cancer72
RNA m6A demethylase FTO-mediated epigenetic up-regulation of LINC00022 promotes tumorigenesis in esophageal squamous cell carcinoma71
Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma71
Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons70
Prevotellaceae produces butyrate to alleviate PD-1/PD-L1 inhibitor-related cardiotoxicity via PPARα-CYP4X1 axis in colonic macrophages69
Mechanisms of cytokine release syndrome and neurotoxicity of CAR T-cell therapy and associated prevention and management strategies69
LncRNA MYLK-AS1 facilitates tumor progression and angiogenesis by targeting miR-424-5p/E2F7 axis and activating VEGFR-2 signaling pathway in hepatocellular carcinoma68
Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma68
RETRACTED ARTICLE: The circular RNA 001971/miR-29c-3p axis modulates colorectal cancer growth, metastasis, and angiogenesis through VEGFA68
Interfering with Tumor Hypoxia for Radiotherapy Optimization68
Molecular Landscape of LncRNAs in Prostate Cancer: A focus on pathways and therapeutic targets for intervention68
The path to the clinic: a comprehensive review on direct KRASG12C inhibitors67
Warburg effect-promoted exosomal circ_0072083 releasing up-regulates NANGO expression through multiple pathways and enhances temozolomide resistance in glioma67
Gut microbiota influence tumor development and Alter interactions with the human immune system66
Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response66
FadA promotes DNA damage and progression of Fusobacterium nucleatum-induced colorectal cancer through up-regulation of chk266
Hypoxia-induced alternative splicing: the 11th Hallmark of Cancer66
The biomarkers related to immune related adverse events caused by immune checkpoint inhibitors66
Cancer-derived exosomal TRIM59 regulates macrophage NLRP3 inflammasome activation to promote lung cancer progression65
Elesclomol: a copper ionophore targeting mitochondrial metabolism for cancer therapy65
The U2AF2 /circRNA ARF1/miR-342–3p/ISL2 feedback loop regulates angiogenesis in glioma stem cells65
0.086477041244507